Factors associated with statin discontinuation near end of life in a Danish primary health care cohort.
Anna Elise EngellLise BathumJohn Sahl AndersenWade ThompsonBent Struer LindHenrik Løvendahl JørgensenJørgen NexøePublished in: Family practice (2022)
A substantial portion of patients continued statin treatment near end of life. Efforts to promote rational statin use and discontinuation are required among patients with limited life expectancy, including establishing clear, practical recommendations about statin discontinuation, and initiatives to translate recommendations into clinical practice.